PubMed Health⌕ Search

Biomedical subjects

M Dudley

Publications and source records attributed to M Dudley.

40 records · Page 3Linked to original sources

Clinical evaluation of new AMS GSC plus card.

The AutoMicrobic System GSC Plus Card was compared to a broth microdilution reference method. Of 1660 minimum inhibitory concentration pairs, 86.1% were within 1 log2 dilution range. A total of 89.2% of the GSC Plus results agreed qualitatively (susceptible, moderately susceptible, resistant). If chloramphenicol data are excluded, agreement is 88.8% and 89.9%, respectively. A total of only 0.90% results were very major or major discrepancies. This is significantly fewer major discrepancies than reported with other systems.

Anti-Bacterial Agents↗

Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.

Several mechanisms render antimicrobials inactive; one of these, beta-lactamase hydrolysis of beta-lactam antimicrobials, is a common and serious problem resulting in loss of antimicrobial activity. Resistance in gram-negative organisms may be caused by chromosomally or plasmid-mediated beta-lactamases. Chromosomally mediated resistance may result from exposure to inducer compounds (induction) or by selection of stably derepressed mutants. Plasmids are extrachromosomal elements of DNA that can transfer resistance between bacteria. Common plasmid-encoded beta-lactamases are the TEM- and SHV-type enzymes, which include the newer extended-spectrum beta-lactamases. Infections caused by resistant bacteria frequently result in longer hospital stays, higher mortality, and increased cost of treatment. When bacteria develop resistance during antimicrobial therapy, therapeutic failure ensues in approximately 50% of patients. Clinical studies demonstrate that resistance mediated by beta-lactamases is a critical issue. Strategies for overcoming it include use of beta-lactam-beta-lactamase inhibitor combinations, development of new antimicrobial compounds, and use of regimens that optimize in vivo exposure to drug.

Anti-Bacterial Agents↗